Enhanced Treatment Precision

Optosense's advanced CTC profiling platform significantly improves the precision of cancer treatments by providing real-time, detailed insights into tumor progression. By accurately detecting and enumerating CTCs, our technology enables clinicians to tailor therapies to the specific needs of each patient. This personalized approach not only enhances the effectiveness of treatments but also minimizes unnecessary side effects, leading to better patient outcomes and overall quality of life.

Our technology is designed to reduce healthcare costs by improving the efficiency and accuracy of cancer diagnostics. With Optosense’s platform, clinicians can make more informed treatment decisions, reducing the likelihood of ineffective therapies and the need for costly follow-up procedures. The ability to precisely target therapies also decreases the financial burden on healthcare systems, making high-quality cancer care more accessible to a broader population.

Optosense’s platform has developed the ability to detect and profile microplastics, which has potential use cases in environmental pollution monitoring and aquafarm management.